2.50
Hdl Handle:
http://hdl.handle.net/10033/311297
Title:
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Authors:
Svindland, Signe C; Pedersen, Gabriel K; Pathirana, Rishi D; Bredholt, Geir; Nøstbakken, Jane K; Jul-Larsen, Åsne; Guzmán, Carlos A; Montomoli, Emanuele; Lapini, Giulia; Piccirella, Simona; Jabbal-Gill, Inderjit; Hinchcliffe, Michael; Cox, Rebecca J
Abstract:
Highly pathogenic avian influenza A/H5N1 virus remains a potential pandemic threat, and it is essential to continue vaccine development against this subtype. A local mucosal immune response in the upper respiratory tract may stop influenza transmission. It is therefore important to develop effective intranasal pandemic influenza vaccines that induce mucosal immunity at the site of viral entry.
Affiliation:
department of vaccinology and applied microbiology, Helmholtz Centre for infection research, D38124 Braunschweig, Germany
Citation:
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. 2013, 7 (6):1181-93 Influenza Other Respir Viruses
Journal:
Influenza and other respiratory viruses
Issue Date:
Nov-2013
URI:
http://hdl.handle.net/10033/311297
DOI:
10.1111/irv.12056
PubMed ID:
23170900
Type:
Article
Language:
en
ISSN:
1750-2659
Appears in Collections:
publications of the research group vaccinology and applied microbiology (VAC)

Full metadata record

DC FieldValue Language
dc.contributor.authorSvindland, Signe Cen
dc.contributor.authorPedersen, Gabriel Ken
dc.contributor.authorPathirana, Rishi Den
dc.contributor.authorBredholt, Geiren
dc.contributor.authorNøstbakken, Jane Ken
dc.contributor.authorJul-Larsen, Åsneen
dc.contributor.authorGuzmán, Carlos Aen
dc.contributor.authorMontomoli, Emanueleen
dc.contributor.authorLapini, Giuliaen
dc.contributor.authorPiccirella, Simonaen
dc.contributor.authorJabbal-Gill, Inderjiten
dc.contributor.authorHinchcliffe, Michaelen
dc.contributor.authorCox, Rebecca Jen
dc.date.accessioned2014-01-14T15:11:57Z-
dc.date.available2014-01-14T15:11:57Z-
dc.date.issued2013-11-
dc.identifier.citationA study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. 2013, 7 (6):1181-93 Influenza Other Respir Virusesen
dc.identifier.issn1750-2659-
dc.identifier.pmid23170900-
dc.identifier.doi10.1111/irv.12056-
dc.identifier.urihttp://hdl.handle.net/10033/311297-
dc.description.abstractHighly pathogenic avian influenza A/H5N1 virus remains a potential pandemic threat, and it is essential to continue vaccine development against this subtype. A local mucosal immune response in the upper respiratory tract may stop influenza transmission. It is therefore important to develop effective intranasal pandemic influenza vaccines that induce mucosal immunity at the site of viral entry.en
dc.language.isoenen
dc.rightsArchived with thanks to Influenza and other respiratory virusesen
dc.titleA study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.en
dc.typeArticleen
dc.contributor.departmentdepartment of vaccinology and applied microbiology, Helmholtz Centre for infection research, D38124 Braunschweig, Germanyen
dc.identifier.journalInfluenza and other respiratory virusesen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.